Menu 

3-day Intensive Workshop for Prior Healthcare Compliance Certificate Program Participants

 


Advanced Healthcare Compliance Certificate Program

3-day Intensive Workshop for Prior Healthcare Compliance Certificate Program Participants

 

[email protected] | 973-642-8382

PROGRAM SCHEDULED for May 14-16, 2024 | Virtual

 
 
 

ABOUT PROGRAM

Seton Hall Law’s Advanced Healthcare Compliance Certificate Program (HCCP) is an intensive, three-day virtual workshop designed for experienced health care compliance and legal professionals who are looking for a deeper dive into key compliance risks, strategic decision making, and policy execution. As the advanced offering, this program builds on the substantive base offered in Seton Hall’s global foundational HCCP. The virtual format is highly participatory, with opportunities for interaction with presenters in each session and a group case study each day to enhance knowledge and application. Expert faculty include legal academics, enforcement officials, compliance professionals, and legal counsel. Attendance at each program will be limited to ensure a small group setting with ample opportunity for participant interaction with faculty and a collegial exchange of ideas. Participants will receive an Advanced HCCP Certificate upon successful completion of the program.

WHO SHOULD ATTEND

The program is designed for compliance and legal professionals who have completed one of Seton Hall Law's global compliance certificate programs (US, APAC, MidEast, LATAM, or EU). The virtual format is highly participatory, with opportunities for interaction with presenters in each session and a group case study each day to enhance knowledge and application.

Tuition cost: $3,150.00

To learn more about this program, contact Brett Canaval at [email protected] or 973-642-8382.

Register for a Deep Dive into Healthcare Compliance in just 3 days!

 
 
 
 
 

PROGRAM OBJECTIVES

This intensive three (3) day program is designed to:

  1. Provide experienced health care compliance and legal professionals with a deeper dive into key compliance risks, strategic decision making, and policy execution
  2. Builds on the substantive base offered in Seton Hall’s global, foundational Health Care Compliance Certificate Programs
  3. Prepare attendees for positions of greater responsibility within their organizations
  4. Promote interactive learning and critical thinking through small group exercises and case studies
  5. Share strategic ideas and best practices on enterprise-level matters including ethics and culture, risk management, and influencing key business leaders
  6. Identify compliance challenges and opportunities in a post-COVID world
  7. Provide networking opportunities with other senior professionals

Program Agenda/Schedule

Day 1 Topics

  1. A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance
  2. Implementation of and Demonstrating Adherence to the Guidance
  3. Risk Assessment Discussion and Case Study

Day 2 Topics

  1. Effective, Ethics-Based Collaboration with Legal and the Business
  2. Third-Party Relationship Management
  3. Case Study: Overseas Third-Party Management

Day 3 Topics

  1. Deep Dive into Internal Investigations
  2. Compliance in a Post-COVID World and Ethical Enterprise Leadership

Compliance Certification Board (CCB) Continuing Education Units (CEUs) are currently pending and expect to be awarded based on individual attendance records.


Note: Agenda. All times are listed in Eastern Time.
DAY 1 - Tuesday

10:00 - 10:45

Program Kickoff, Overview, and Participant Introductions

Rosa Alves

Rosa M. Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School

Learn more about Rosa M. Alves

Jacob Elberg

Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Learn more about Jacob T. Elberg

10:50 – 12:05

A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance

Jacob Elberg

Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Learn more about Jacob T. Elberg

Lauren Kootman

Lauren Kootman
Assistant Chief, Corporate Enforcement, Compliance & Policy Unit, Fraud Section, Criminal Division, U.S. Department of Justice
Learn more about Lauren Kootman

Daniel Kahn

Daniel Kahn
Partner, Davis Polk & Wardwell LLP

Learn more about Daniel Kahn

12:05 – 1:05

Lunch Break

1:05 – 2:25

Implementation of and Demonstrating Adherence to the Guidance 

Gary Giampetruzzi

Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings LLP

Learn more about Gary Giampetruzzi

Sujata Dayal

Sujata Dayal
Vice President & Chief Compliance Officer, Medline Industries, Inc.

Learn more about Sujata Dayal

Melissa Lozner

Melissa Lozner, J.D.
Senior Vice President, Chief Compliance Officer, Regeneron

Learn more about Melissa Lozner, J.D.

Robert Ladd

Robert Ladd
Vice President, Global Head SpeakUp Office – Ethics, Risk & Compliance, Novartis

Learn more about Robert Ladd

2:25 – 2:40

Break

2:40 – 4:40

Risk Assessment Discussion and Case Study:

  1. Overview of Enterprise Risk Assessment
  2. Approaches to Compliance Risk Assessment
  3. Case Study
Christie Camelio

Christie Camelio
Senior Vice President, Chief Compliance & Risk Officer, EQRx

Learn more about Christie Camelio

Edward Leskauskas

Edward Leskauskas
Head of CIA Mandated Monitoring & Reporting, NA Ethics & Business Integrity, Sanofi

Richard Konzelmann

Richard Konzelmann
Lead U.S Risk Assessment and Compliance Audits - U.S. Ethics and Business Integrity, Sanofi

 

DAY 2 - Wednesday

9:30 – 11:00

Effective, Ethics-Based Collaboration with Legal and the Business

Piergiorgio Pepe

Piergiorgio Pepe
President, Quantum Ethics

Learn more about Piergiorgio Pepe

Lawrence Platkin

Lawrence Platkin
Vice President and Head, U.S. Office of Compliance (Retired), Bayer U.S. LLC

Learn more about Lawrence Platkin

Signe Elbaek

Signe Elbaek
Chief Compliance Officer, Mölnlycke AB

Learn more about Signe Elbaek

Timothy Glynn

Timothy Glynn
Andrea J. Catania Endowed Professor of Law, Seton Hall Law School
Learn more about Professor Timothy Glynn

11:00 – 11:15

Break

11:15 – 12:45

Third-Party Relationship Management 

  1. Domestic and Global Risks, Due Diligence, Contracting, Monitoring, Auditing, Termination
Jaimee Reid

Jaimee Reid
Senior Director, Legal Compliance, Intercept Pharmaceuticals

Learn more about Jaimee Reid

S. Joy Dowdle

S. Joy Dowdle
Partner, Litigation Department, Paul Hastings LLP

Learn more about S. Joy Dowdle

12:45 – 1:45

Lunch Break

1:45 – 3:30

Case Study: Overseas Third Party Management

Jaimee Reid

Jaimee Reid
Senior Director, Legal Compliance, Intercept Pharmaceuticals

Learn more about Jaimee Reid

S. Joy Dowdle

S. Joy Dowdle
Partner, Litigation Department, Paul Hastings LLP

Learn more about S. Joy Dowdle

3:30 – 4:15

Networking Reception for All Program Faculty & Attendees

DAY 3 - Thursday

10:00 – 11:45

Compliance in a Post-COVID World and Ethical Enterprise Leadership 

  1. Influencing business leadership, including the Board to confront compliance challenges that would emerge post-COVID
Bryant Aaron

Bryant Aaron
Chief Compliance Officer, Elevance Health, Inc. (f/k/a Anthem, Inc.)

Learn more about Bryant Aaron

Anisa Dhalla

Anisa Dhalla
Head of Global Ethics & Compliance, UCB, Inc.

Learn more about Anisa Dhalla

Jennifer McGee

Jennifer McGee
Senior Vice President & Global Chief Compliance Officer, Otsuka Pharmaceuticals, Inc.

Learn more about Jennifer McGee

Jacob Elberg

Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Learn more about Jacob T. Elberg

11:45 – 12:45

Lunch Break

12:45 – 1:45

Deep Dive into Internal Investigations 

  1. Strategies, Techniques, Tools (Analytics, etc.)
Joseph Zimmerman

Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.

Learn more about Joseph Zimmerman

Anisa Dhalla

Anisa Dhalla
Head of Global Ethics & Compliance, UCB, Inc.

Learn more about Anisa Dhalla

Adam Weinstein

Adam Weinstein
Litigation & Compliance Counsel, Candela Medical

Learn more about Adam Weinstein

1:45 – 2:00

Break

2:00 – 3:45

Case Study

Joseph Zimmerman

Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.

Learn more about Joseph Zimmerman

Anisa Dhalla

Anisa Dhalla
Head of Global Ethics & Compliance, UCB, Inc.

Learn more about Anisa Dhalla

Adam Weinstein

Adam Weinstein
Litigation & Compliance Counsel, Candela Medical

Learn more about Adam Weinstein

3:45 – 4:00

Conclusion & Closing Remarks